Physician-scientist. Clinical medicine, development, and regulation.

Dr. Damon Tojjar

I trained and worked as a physician across the full arc of clinical medicine, then in global drug development at Novo Nordisk, with an M.D. from Lund University, Ph.D.-candidate research in diabetes genetics, and formal training in Good Clinical Practice and medical-device regulation. Today I explain and evaluate clinical evidence as a physician-scientist rather than treat patients.

  • M.D.Lund University
  • Novo NordiskGlobal Development
  • FDAClinical Investigator training
  • EU MDRdevice-regulation training

Clinical medicine

A physician's training and practice, as documented.

Before his work in drug development and health technology, Dr. Tojjar trained and worked as a physician across the full arc of clinical medicine. He earned his M.D. at Lund University, whose medical school had the lowest acceptance rate in Sweden at the time of his admission, and achieved top-percentile results on the national medical board examinations, with all four oral clinical case examinations (internal medicine, surgery, psychiatry, and family medicine) rated Utmarkt (Outstanding), the highest mark.

He completed a clinical internship (Forskar-AT) at Skane University Hospital in Lund and Malmo, rotating through the emergency department, surgery (general, orthopedic, hand, breast, and melanoma), anesthesia and intensive care, urology, internal medicine, psychiatry, and primary care, and was the only graduate of his class offered a Skane University Hospital internship immediately, through a competitive interview. He served as a junior doctor in orthopedic surgery and as a physician-scientist in the Department of Endocrinology, Sweden's oldest, combining in-ward and outpatient endocrine and diabetes care with research.

As a family physician in Swedish primary care he integrated outpatient practice with clinical research in diabetes and chronic-disease management, and he provided pro bono medical care for underprivileged people and refugees. His formal training evaluations were consistently rated Utmarkt (Outstanding), with particular strength in patient interaction, clinical examination, and diagnostic reasoning.

This page describes Dr. Tojjar's clinical history. Today he works as a physician-scientist and reference voice, explaining and evaluating clinical evidence, and does not provide individual medical advice.

Areas of focus

Where medicine, development, and regulation meet.

Clinical trials and Good Clinical Practice

Designing and running clinical programs to a standard that holds up under scrutiny, from protocol to readout, informed by FDA Clinical Investigator training.

Drug development

Global development experience at Novo Nordisk as International Medical Manager and Principal Medical Specialist on GLP-1, insulin, and combination therapies, keeping the evidence solid while the work ran across many countries.

Medical-device and SaMD regulation

How a clinical claim earns its place at the point of care under EU MDR, IVDR, FDA pathways, and Software as a Medical Device, from KTH medical-device-regulations training.

Clinical AI validation

Translating evidence into decision support that is tested before it is trusted, evaluated in the EASY-1 randomized controlled trial.

Clinical and translational work

From development to the point of care.

  1. Novo Nordisk, Global Development

    International Medical Manager and Principal Medical Specialist

    Helped lead global clinical programs for GLP-1, insulin, and combination therapies, including Tresiba, Ryzodeg, and Xultophy, keeping the clinical evidence solid while the work ran across many countries.

  2. EASY Diabetes

    Co-developer and Head of Medical and Science

    An AI-based clinical decision-support system for type 2 diabetes, developed with patients, clinicians, and researchers. Its randomized controlled trial, EASY-1 (NCT03258268), compared the system against standard of care. EASY Diabetes received the Medtech4Health Innovation Award.

Training: FDA Clinical Investigator training; Medical Device Regulations training, KTH (EU MDR, IVDR, FDA, Software as a Medical Device); Health Care Outcomes Management, Harvard T.H. Chan School of Public Health. Peer-reviewed publications are collected at Tojjar Lab.

Frequently asked

Clinical medicine, development, and regulation.

What is Dr. Tojjar's clinical background?

He trained and worked as a physician across the full arc of clinical medicine: a clinical internship at Skane University Hospital spanning the emergency department, surgery, anesthesia and intensive care, urology, internal medicine, psychiatry, and primary care; junior-doctor work in orthopedic surgery; a physician-scientist post in endocrinology; and family practice in Swedish primary care, alongside pro bono care for underprivileged people and refugees. His clinical training evaluations were consistently rated Utmarkt (Outstanding). Today he explains and evaluates clinical evidence as a physician-scientist and does not treat patients.

What is Dr. Tojjar's clinical and regulatory expertise?

Global drug development (International Medical Manager and Principal Medical Specialist at Novo Nordisk on GLP-1, insulin, and combination therapies, including Tresiba, Ryzodeg, and Xultophy), clinical trials and Good Clinical Practice (FDA Clinical Investigator training), and medical-device and Software-as-a-Medical-Device regulation (EU MDR, IVDR, FDA; KTH medical-device-regulations training).

What is EASY Diabetes?

An AI clinical decision-support system for type 2 diabetes that Dr. Tojjar co-developed and led as Head of Medical and Science; it was evaluated in the EASY-1 randomized controlled trial and recognized with the Medtech4Health Innovation Award.

What are his credentials?

M.D. from Lund University and Ph.D. candidate in medical science (Lund University Diabetes Centre), with a Stanford research fellowship in systems medicine under Professor Atul Butte. He explains and evaluates medical evidence as a physician-scientist and does not provide medical care or treat patients.

Contact

Get in touch.

For clinical-development, regulatory, or advisory collaboration, reach out directly.

contact@doctortojjar.com